Cibc Private Wealth Group, LLC Crispr Therapeutics Ag Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,614 shares of CRSP stock, worth $85,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,614
Previous 12,395
86.98%
Holding current value
$85,735
Previous $775,000
85.81%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CRSP
# of Institutions
549Shares Held
56.3MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$433 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$416 Million0.11% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.27MShares$174 Million0.16% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$174 Million2.23% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$144 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.14B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....